Neurobiology of Aging
Volume 30, Issue 10 , Pages 1614-1625 , October 2009

Septal grafts restore cognitive abilities and amyloid precursor protein metabolism

  • Eugenio Aztiria

      Affiliations

    • B.R.A.I.N. Centre for Neuroscience, Department of Physiology and Pathology, University of Trieste, Via Fleming 22, 34127 Trieste, Italy
    • These authors contributed equally to the study.
  • ,
  • Tiziana Cataudella

      Affiliations

    • B.R.A.I.N. Centre for Neuroscience, Department of Physiology and Pathology, University of Trieste, Via Fleming 22, 34127 Trieste, Italy
    • These authors contributed equally to the study.
  • ,
  • Santi Spampinato

      Affiliations

    • Department of Pharmacology, University of Bologna, Italy
  • ,
  • Giampiero Leanza

      Affiliations

    • B.R.A.I.N. Centre for Neuroscience, Department of Physiology and Pathology, University of Trieste, Via Fleming 22, 34127 Trieste, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 040 5587904; fax: +39 040 567862.

Received 1 October 2007 ,Revised 12 December 2007 ,Accepted 19 December 2007.

References 

  1. Araki W, Kunishita T, Takahashi K, Ikeda S, Tabira T. Secretion kinetics of Alzheimer's amyloid beta-protein differs from secreted beta-amyloid precursor protein. Biochem. Biophys. Res. Commun. 1995;214:490–495
  2. Beach TG, Walker DG, Cynader MS, Hughes LH. Increased beta-amyloid precursor protein mRNA in the rat cerebral cortex and hippocampus after chronic systemic atropine treatment. Neurosci. Lett. 1996;210:13–16
  3. Beeson JG, Shelton ER, Chan HW, Gage FH. Age and damage induced changes in amyloid protein precursor immunohistochemistry in the rat brain. J. Comp. Neurol. 1994;342:69–77
  4. Berger-Sweeney J, Heckers S, Mesulam MM, Wiley RG, Lappi DA, Sharma M. Differential effects on spatial navigation of immunotoxin-induced cholinergic lesions of the medial septal area and nucleus basalis magnocellularis. J. Neurosci. 1994;14:4507–4519
  5. Björklund A, Stenevi U, Schmidt RH, Dunnett SB, Gage FH. Intracerebral grafting of neuronal cell suspensions. I. Introduction and general methods of preparation. Acta Physiol. Scand. Suppl. 1983;522:1–7
  6. Björklund A, Dunnett SB. Neural transplantation in adult rats. In:  Dunnett SB,  Björklund A editor. Neural Transplantation. A Practical Approach. Oxford: Oxford University Press; 1992;p. 57–78
  7. Browne SE, Lin L, Mattsson A, Georgievska B, Isacson O. Selective antibody-induced cholinergic cell and synapse loss produce sustained hippocampal and cortical hypometabolism with correlated cognitive deficits. Exp. Neurol. 2001;170:36–47
  8. Capsoni S, Ugolini G, Comparini A, Ruberti F, Berardi N, Cattaneo A. Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice. PNAS. 2000;97:6826–6831
  9. Checler F. Processing of the beta-amyloid precursor protein and its regulation in Alzheimer's disease. J. Neurochem. 1995;65:1431–1444
  10. Efthimiopoulos S, Vassilacopoulou D, Ripellino JA, Tezapsidis N, Robakis NK. Cholinergic agonists stimulate secretion of soluble full-length amyloid precursor protein in neuroendocrine cells. PNAS. 1996;93:8046–8050
  11. Esch FS, Keim PS, Beattie EC, Blacher RW, Culwell AR, Oltersdorf T, et al. Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science. 1990;248:1122–1124
  12. Farber SA, Nitsch RM, Schulz JG, Wurtman RJ. Regulated secretion of beta-amyloid precursor protein in rat brain. J. Neurosci. 1995;15:7442–7451
  13. Giovannelli L, Casamenti F, Scali C, Bartolini L, Pepeu G. Differential effects of amyloid peptides beta-(1–40) and beta-(25–35) injections into the rat nucleus basalis. Neuroscience. 1995;66:781–792
  14. Haass C, Schlossmacher MG, Hung AY, Vigo-Pelfrey C, Mellon A, Ostaszewski BL, et al. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature. 1992;359:322–325
  15. Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science. 1992;256:184–185
  16. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002;297:353–356
  17. Harkany T, Lengyel Z, Soos K, Penke B, Luiten PG, Gulya K. Cholinotoxic effects of beta-amyloid (1–42) peptide on cortical projections of the rat nucleus basalis magnocellularis. Brain Res. 1995;695:71–75
  18. Harkany T, De Jong GI, Soos K, Penke B, Luiten PG, Gulya K. Beta-amyloid (1–42) affects cholinergic but not parvalbumin-containing neurons in the septal complex of the rat. Brain Res. 1995;698:270–274
  19. Heckers S, Ohtake T, Wiley RG, Lappi DA, Geula C, Mesulam MM. Complete and selective cholinergic denervation of rat neocortex and hippocampus but not amygdala by an immunotoxin against the p75 NGF receptor. J. Neurosci. 1994;14:1271–1289
  20. Hedreen JC, Bacon SJ, Price DL. A modified histochemical technique to visualize acetylcholinesterase-containing axons. J. Histochem. Cytochem. 1985;33:134–140
  21. Hellstrom-Lindahl E. Modulation of beta-amyloid precursor protein processing and tau phosphorylation by acetylcholine receptors. Eur. J. Pharmacol. 2000;393:255–263
  22. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science. 1996;274:99–102
  23. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 1987;325:733–736
  24. Kar S, Seto D, Gaudreau P, Quirion R. Beta-amyloid-related peptides inhibit potassium-evoked acetylcholine release from rat hippocampal slices. J. Neurosci. 1996;16:1034–1040
  25. Kar S, Slowikowski SP, Westaway D, Mount HT. Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease. J. Psychiat. Neurosci. 2004;29:427–441
  26. Kirazov L, Loffler T, Schliebs R, Bigl V. Glutamate-stimulated secretion of amyloid precursor protein from cortical rat brain slices. Neurochem. Int. 1997;30:557–563
  27. Koo EH, Park L, Selkoe DJ. Amyloid beta-protein as a substrate interacts with extracellular matrix to promote neurite outgrowth. PNAS. 1993;90:4748–4752
  28. Leanza G, Nilsson OG, Björklund A. Functional activity of intrahippocampal septal grafts is regulated by catecholaminergic host afferents as studied by microdialysis of acetylcholine. Brain Res. 1993;618:47–56
  29. Leanza G, Nilsson OG, Wiley RG, Björklund A. Selective lesioning of the basal forebrain cholinergic system by intraventricular 192 IgG-saporin: behavioural, biochemical and stereological studies in the rat. Eur. J. Neurosci. 1995;7:329–343
  30. Leanza G. Chronic elevation of amyloid precursor protein expression in the neocortex and hippocampus of rats with selective cholinergic lesions. Neurosci. Lett. 1998;257:53–56
  31. Leanza G, Martinez-Serrano A, Björklund A. Amelioration of spatial navigation and short-term memory deficits by grafts of foetal basal forebrain tissue placed into the hippocampus and cortex of rats with selective cholinergic lesions. Eur. J. Neurosci. 1998;10:2353–2370
  32. Lee RK, Wurtman RJ, Cox AJ, Nitsch RM. Amyloid precursor protein processing is stimulated by metabotropic glutamate receptors. PNAS. 1995;92:8083–8087
  33. Lin L, LeBlanc CJ, Deacon TW, Isacson O. Chronic cognitive deficits and amyloid precursor protein elevation after selective immunotoxin lesions of the basal forebrain cholinergic system. Neuroreport. 1998;9:547–552
  34. Lin L, Georgievska B, Mattsson A, Isacson O. Cognitive changes and modified processing of amyloid precursor protein in the cortical and hippocampal system after cholinergic synapse loss and muscarinic receptor activation. PNAS. 1999;96:12108–12113
  35. Maurice T, Lockhart BP, Privat A. Amnesia induced in mice by centrally administered β-amyloid peptides involves cholinergic dysfunction. Brain Res. 1996;706:181–193
  36. Meziane H, Dodart JC, Mathis C, Little S, Clemens J, Paul SM, et al. Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice. PNAS. 1998;95:12683–12688
  37. Mills J, Reiner PB. Regulation of amyloid precursor protein cleavage. J. Neurochem. 1999;72:443–460
  38. Milward EA, Papadopoulos R, Fuller SJ, Moir RD, Small D, Beyreuther K, et al. The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth. Neuron. 1992;9:129–137
  39. Moran, P.M., Higgins, L.S., Cordell, B., Moser, P.C., 1995. Age-related learning deficits in transgenic mice expressing the 751-amino acid isoform of human ß-amyloid precursor protein. PNAS 92, 5341–5345.
  40. Mori F, Lai CC, Fusi F, Giacobini E. Cholinesterase inhibitors increase secretion of APPs in rat brain cortex. Neuroreport. 1995;6:633–666
  41. Morris RGM. Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods. 1984;11:47–60
  42. Muller DM, Mendla K, Farber SA, Nitsch RM. Muscarinic M1 receptor agonists increase the secretion of the amyloid precursor protein ectodomain. Life Sci. 1997;60:985–991
  43. Neve RL, Rogers J, Higgins GA. The Alzheimer amyloid precursor-related transcript lacking the beta/A4 sequence is specifically increased in Alzheimer's disease brain. Neuron. 1990;5:329–338
  44. Neve RL, Robakis NK. Alzheimer's disease: a re-examination of the amyloid hypothesis. Trends Neurosci. 1998;21:15–19
  45. Nitsch RM, Slack BE, Wurtman RJ, Growdon JH. Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science. 1992;258:304–307
  46. Nitsch RM, Farber SA, Growdon JH, Wurtman RJ. Release of amyloid β-protein precursor derivatives by electrical depolarization of rat hippocampal slices. PNAS. 1993;90:5191–5193
  47. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd Edition. Academic Press; 1986;
  48. Pedersen WA, Kloczewiak MA, Blusztajn JK. Amyloid beta-protein reduces acetylcholine synthesis in a cell line derived from cholinergic neurons of the basal forebrain. PNAS. 1996;93:8068–8071
  49. Pittel Z, Heldman E, Barg J, Haring R, Fisher A. Muscarinic control of amyloid precursor protein secretion in rat cerebral cortex and cerebellum. Brain Res. 1996;742:299–304
  50. Potter PE, Gaughan C, Assouline Y. Lesion of septal-hippocampal neurons with 192 IgG-saporin alters function of M1 muscarinic receptors. Neuropharmacology. 1999;38:579–586
  51. Racchi M, Sironi M, Caprera A, König G, Govoni S. Short- and long-term effect of acetylcholinesterase inhibition on the expression and metabolism of the amyloid precursor protein. Mol. Psychiatry. 2001;6:520–528
  52. Rasband WS, Bright DS. NIH Image: a public domain image processing program for the Macintosh. Microbeam Anal. Soc. J. 1995;4:37–149
  53. Robertson MR, Harrel LE. Cholinergic activity and amyloid precursor protein metabolism. Brain Res. Rev. 1997;25:50–69
  54. Rosenblad C, Nilsson OG. Basal forebrain grafts in the rat neocortex restore in vivo acetylcholine release and respond to behavioural activation. Neuroscience. 1993;55:353–362
  55. Rossner S, Ueberham U, Yu J, Kirazov L, Schliebs R, Perez-Polo JR, et al. In vivo regulation of amyloid precursor protein secretion in rat neocortex by cholinergic activity. Eur. J. Neurosci. 1997;9:2125–2134
  56. Rossner S, Ueberham U, Schliebs R, Perez-Polo JR, Bigl V. The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling. Prog. Neurobiol. 1998;56:541–569
  57. Schliebs R. Basal forebrain cholinergic dysfunction in Alzheimer's disease-interrelationship with beta-amyloid, inflammation and neurotrophin signaling. Neurochem. Res. 2005;30:895–908
  58. Segal M, Greenberger V, Pearl E. Septal transplants ameliorate spatial deficits and restore cholinergic functions in rats with a damaged septo-hippocampal connection.. Brain Res. 1989;500:139–148
  59. Selkoe DJ. Alzheimer's disease: genotypes, phenotypes, and treatments. Science. 1997;275:630–631
  60. Selkoe DJ, Schenk D. Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. Annu. Rev. Pharmacol. Toxicol. 2003;43:545–584
  61. Seo J, Kim S, Kim H, Park CH, Jeong S, Lee J, et al. Effects of nicotine on APP secretion and Abeta- or CT(105)-induced toxicity. Biol. Psychiatry. 2001;49:240–247
  62. Seo H, Isacson O. Abnormal APP, cholinergic and cognitive function in Ts65Dn Down's model mice. Exp. Neurol. 2005;193:469–480
  63. Shoji M, Golde TE, Ghiso J, Cheung TT, Estus S, Shaffer LM, et al. Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science. 1992;258:126–129
  64. Tarricone BJ, Simon JR, Low WC. Intrahippocampal transplants of septal cholinergic neurons: choline acetyltransferase activity, muscarinic receptor binding, and spatial memory function. Brain Res. 1993;632:41–47
  65. Waite JJ, Chen AD, Wardlow ML, Wiley RG, Lappi DA, Thal LJ. 192 immunoglobulin G-saporin produces graded behavioral and biochemical changes accompanying the loss of cholinergic neurons of the basal forebrain and cerebellar Purkinje cells. Neuroscience. 1995;65:463–476
  66. Wallace W, Ahlers ST, Gotlib J, Bragin V, Sugar J, Gluck R, et al. Amyloid precursor protein in the cerebral cortex is rapidly and persistently induced by loss of subcortical innervation. PNAS. 1993;90:8712–8716
  67. Wallace WC, Lieberburg I, Schenk D, Vigo-Pelfrey C, Davis KL, Haroutunian V. Chronic elevation of secreted amyloid precursor protein in subcortically lesioned rats, and its exacerbation in aged rats. J. Neurosci. 1995;15:4896–4905
  68. West MJ, Slomianka L, Gundersen HJ. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat. Rec. 1991;231:482–497
  69. Wiley RG, Oeltmann TN, Lappi DA. Immunolesioning: selective destruction of neurons using immunotoxin to rat NGF receptor.. Brain Res. 1991;562:149–153
  70. Zheng WH, Bastianetto S, Mennicken F, Ma W, Kar S. Amyloid beta peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures. Neuroscience. 2002;115:201–211

PII: S0197-4580(07)00491-5

doi: 10.1016/j.neurobiolaging.2007.12.018

Neurobiology of Aging
Volume 30, Issue 10 , Pages 1614-1625 , October 2009